Skip to content

Enbrel SMARTCLIC

by PHC Corporation 3 variants

Ref APP-1000-05, APP-1000-02, APP-1000-08Model APP-1000

Enbrel SMARTCLIC (APP-1000-05) is a medical device (EU MDR Class IIa; EMDN category portable pain therapy instruments) made by Phc Corporation, registered in EUDAMED on 10 Feb 2022 (Basic UDI-DI 4987905INJECTORMJ), active as of 22 Oct 2026.

Active European Union

CE MDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number4987905INJECTORMJ Basic UDI-DI Date10 Feb 2022RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device name
Injection Device
Model / reference
APP-1000, APP-1000-05, APP-1000-02, APP-1000-08
Primary DI / UDI-DI
04987905000129, 04987905000099, 04987905000150
Basic UDI-DI
4987905INJECTORMJ
Direct marketing DI
04987905000075
EMDN code
Z1204021602 Portable pain therapy instruments
Device class
Class IIa
EU registration type
Standard device
EU market of registration
Belgium

Manufacturer details

EUDAMED SRN
JP-MF-000008188
Authorised representative
PHC Europe B.V. NL-AR-000002692

Similar devices in this category

Other devices filed under PORTABLE MICROINFUSION INSTRUMENTS.

Other devices from Phc Corporation

See all devices from Phc Corporation →

Properties

  • Contains CMR substances (carcinogenic, mutagenic or toxic to reproduction)
  • Administering medicine
Other properties (12, all answered No)